Skip to content
Open access

Delayed astrocyte development impairs Sema6a-Plxna2/4-mediated astrocyte-neuron crosstalk and causes depressive-like behavior

Jul 2026 · Nature Communications · Vol 17 · 0 citations
Medicine

TL;DR

It is demonstrated that Egfr knockout during the critical period of neuronal maturation results in a transient absence of astrocytes, with recovery observed in adult mice, and developmental disruption of EGFR signaling leads to transient astrocyte loss and impaired astrocyte–neuron crosstalk.

Abstract

Neural functions and circuit formation rely on intricate crosstalk among various cell types during critical periods. Disruptions or delays in this crosstalk between neurons and astrocytes lead to abnormal neural functions and neurodevelopmental disorders. However, the lack of robust mouse models to study the crosstalk between astrocytes and neurons thus renders unclear the implications of impeding such interactions. In this study, we demonstrate that Egfr knockout during the critical period of neuronal maturation results in a transient absence of astrocytes, with recovery observed in adult mice. This model thus provides a unique opportunity to investigate the effects of impaired astrocyte-neuron communication during development. Mechanically, we show that loss of Egfr disrupts the Egfr-pERK-Epb41l2 signaling axis, which in turn prevents glial progenitor cells from migrating outward. More importantly, Egfr deficiency during the critical period compromises astrocyte-neuron communication via the Sema6a-Plxna2/4 ligand-receptor pair. This impaired intercellular crosstalk reduces neuronal dendritic complexity and excitability, ultimately culminating in depressive-like behaviors in adult mice. This study shows that developmental disruption of EGFR signaling leads to transient astrocyte loss and impaired astrocyte–neuron crosstalk. Altered EGFR–pERK–EPB41L2 signaling and Sema6a–Plxna2/4 communication, results in reduced dendritic complexity, neuronal excitability, and long-term depressive-like behaviours.

Read PDF

Similar papers

Open access Jul 2026

Impaired astrocyte-to-neuron cholesterol trafficking drives synaptic dysfunction in Rett syndrome

Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder caused by loss-of-function mutations in the MECP2 gene and characterized by profound impairments in neuronal maturation and synaptic connectivity. Increasing evidence indicates that astrocyte dysfunction contributes to RTT pathogenesis through non-cel...

Francesca M. Postogna, Noemi Giancroce, C. Cabasino et al. · 0 citations
Open access Jul 2026

Mutant Huntingtin disrupts neurogenic and astroglial programs via the EZH2-Let-7g-LIN28 axis with rescue by epigenetic modulators.

It is shown that neurogenesis is disrupted at multiple stages of lineage progression in both rodent and human neural stem cell models of Huntington's disease, and a panel of clinically relevant epigenetic compounds hold promise for stage-spanning therapeutic strategies capable of modifying disease trajectory.

Jessica Rosati, A. Casamassa, G. Ruotolo et al. · 0 citations
Aug 2026

Astrocytic LCN2 mediates pathological crosstalk with neurons to promote neuronal loss in sepsis-associated encephalopathy.

This study demonstrates that increased secretion of LCN2 from hippocampal astrocytes in SAE mice binds to the neuronal receptor 24p3R, thereby inducing neuronal damage and suggests an etiopathogenic mechanism of SAE, initiated by the increased astrocytic secretion of LCN2.

Cui-Ping Guo, Yi Liu, Wensheng Li et al. · 0 citations
Review Sep 2026

[Gq-GPCR upregulation in reactive astrocytes: implication for neurological disorders].

The P2Y1R-IGFBP2 signaling axis is identified as a common pathological feature of reactive astrocytes across brain diseases and IGFBP2 is established as a novel glial-derived factor that could promote neuronal hyperexcitability.

E. Shigetomi, Schuichi Koizumi · 0 citations
Open access Sep 2026

Defective EV-mediated transport of SHH alters neural fate specification in EPM1 epilepsy

The results demonstrate that EPM1 COs display increased electrophysiological activity and disrupted excitatory/inhibitory (E/I) balance, and identify the CSTB-SHH-EV axis as a potential therapeutic target for mitigating the E/I imbalance associated with EPM1.

Andrea Forero, V. Pravata, Fabrizia Pipicelli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.